Graphite Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Graphite Bio and buy or sell other stocks, ETFs, and their options commission-free!About GRPH
LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia.
CEOEvert B. Schimmelpennink
CEOEvert B. Schimmelpennink
Employees42
Employees42
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded
Founded
Employees42
Employees42
GRPH Key Statistics
Market cap467.99M
Market cap467.99M
Price-Earnings ratio-7.77
Price-Earnings ratio-7.77
Dividend yield—
Dividend yield—
Average volume1.64M
Average volume1.64M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$50.40
52 Week high$50.40
52 Week low$15.70
52 Week low$15.70
Stock Snapshot
Graphite Bio(GRPH) stock is priced at $16.37, giving the company a market capitalization of 467.99M. It carries a P/E multiple of -7.77.
Graphite Bio(GRPH) stock opened on 2025-12-18 at —. The price climbed to — and dipped to —.
Graphite Bio(GRPH) shares are trading with a volume of 0, against a daily average of 1.64M.
In the last year, Graphite Bio(GRPH) shares hit a 52-week high of $50.40 and a 52-week low of $15.70.
In the last year, Graphite Bio(GRPH) shares hit a 52-week high of $50.40 and a 52-week low of $15.70.
People also own
Based on the portfolios of people who own GRPH. This list is generated using Robinhood data, and it’s not a recommendation.